Patents by Inventor Jurgen Harting

Jurgen Harting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kappa agonists, especialy for the treatment and/or prophylaxis of irritable bowel syndrome
    Publication number: 20060178426
    Abstract: Compound of the formula (I), in which A, R1, R2, R3, X, Y, m and n have the meaning indicated, are suitable as for the treatment of irritable bowel syndrome.
    Type: Application
    Filed: June 18, 2004
    Publication date: August 10, 2006
    Inventors: Wolfgang Stahle, Rudolf Gottschlich, Jurgen Harting, Christoph Seyfried
  • Piperidine alcohols
    Patent number: 6756370
    Abstract: The invention relates to compounds of formula (I), wherein R1, R2 and A have the meanings given in claim 1, are potent 5-HT2A antagonists and are suitable for treating psychoses, schizophrenia, depression, neurological disorders, impaired memory, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Huntington's disease, eating disorders such as bulimia and anorexia nervosa, Pre-Menstrual Syndrome and/or for positively influencing obsessive-compulsive disorders, (OCD).
    Type: Grant
    Filed: February 21, 2002
    Date of Patent: June 29, 2004
    Assignee: Merck Patent GmbH
    Inventors: Helmut Prücher, Henning Böttcher, Karl-August Ackermann, Rudolf Gottschlich, Christoph van Amsterdam, Christoph Seyfried, Jürgen Harting, Gerd Bartoszyk, Hartmut Greiner
  • Piperazinylcarbonylquinolines and -isoquinolines
    Publication number: 20040077657
    Abstract: Compound of the formula (I) in which R1, R2 and alk are as defined in Claim 1, are potent 5-HT2A antagonist and are suitable for the treatment of psychoses, schizophrenia, depression, neurological disorders, memory disorders, Parkinson's disease, amyotrophic lateral sclerosis, Alzheimer's disease, Hutington's disease, eating disorders, such as bulimia, anorexia nervosa, premenstrual syndrome and/or for positively influencing obsessive-compulsive disorder (OCD).
    Type: Application
    Filed: July 17, 2003
    Publication date: April 22, 2004
    Inventors: Henning Bottcher, Gerd Bartoszyk, Jurgen Harting, Christoph van Amsterdam, Christoph Seyfried
  • Indole derivatives
    Patent number: 6723725
    Abstract: Indole derivatives of formula I, their salts and solvates, have valuable pharmacological properties together with good tolerability, as they have actions on the central nervous system: wherein R1 and R3 are as defined herein. The compounds have a strong affinity for 5-HT2A receptors, and furthermore exhibit 5HT2A receptor-antagonistic properties. These are therefore suitable both in veterinary and in human medicine for the treatment of functional disorders of the central nervous system and also of inflammation.
    Type: Grant
    Filed: January 22, 2002
    Date of Patent: April 20, 2004
    Assignee: Merck Patent GmbH
    Inventors: Henning Böttcher, Joachim März, Hartmut Greiner, Jürgen Harting, Gerd Bartoszyk, Christoph Seyfried, Christoph van Amsterdam
  • Arylpiperazine derivatives and their use as psychotropic agents
    Publication number: 20040014972
    Abstract: The invention relates to arylpiperazine derivatives of formula (I), wherein R1, R2, A, B, Ar and n have the given meanings.
    Type: Application
    Filed: March 5, 2003
    Publication date: January 22, 2004
    Inventors: Rudolf Gottschlich, Dieter Dorsch, Gerd Bartosyk, Jurgen Harting, Christoph Seyfried, Christoph van Amsterdam
  • Pyridaziny or oxodihydropyridazinyl chroman derivatives
    Patent number: 5238937
    Abstract: The invention relates to novel chroman derivatives of the formula I ##STR1## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 have the meanings given in [Patent claim 1], and which, like their salts, show effects on the cardiovascular system and can be used for the treatment or prophylaxis of cardiac insufficiency, angina pectoris, high blood pressure, incontinence and alopecia.
    Type: Grant
    Filed: December 4, 1991
    Date of Patent: August 24, 1993
    Assignee: Merck Patent Gesellschaft
    Inventors: Rolf Gericke, Manfred Baumgarth, Ingeborg Lues, Jurgen Harting, Rolf Bergmann
  • Pharmaceutical compositions containing 2-aryltetraazaindenes for treating ulcers or cardiac insufficiency or blood pressure abnormalities
    Patent number: 4575505
    Abstract: 2-Aryltetraazaindenes of the formula ##STR1## wherein --A-- is --N.dbd.CH--CH.dbd.N-- or --CH.dbd.N--N.dbd.CH--, Ar is unsubstituted phenyl or phenyl mono-, di- or trisubstituted by hydroxyl, mercapto, dialkylamino, trifluoromethyl and/or --Z--R groups, Z is --O--, --S-- or --SO-- and R is alkyl, alkenyl, alkynyl or cyanomethyl, the alkyl, alkenyl and alkynyl groups each having up to 5 C atoms, and their physiologially acceptable salts, exhibit blood pressure, myocardial contraction, and anti-ulcer activities.
    Type: Grant
    Filed: July 26, 1984
    Date of Patent: March 11, 1986
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Rochus Jonas, Michael Kloft, Hanns Wurziger, Jurgen Harting, Hans J. Enenkel, Klaus-Otto Minck, Hans-Jochen Schliep
  • 1-(p-2-Isopropoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol for decreasing the intra-ocular pressure and an ophthalmic preparation thereof
    Patent number: 4522829
    Abstract: 1-(p-2-iso-propoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol and its biocompatible salts are very useful in decreasing the intra-ocular pressure, e.g., to treat glaucoma.
    Type: Grant
    Filed: June 30, 1982
    Date of Patent: June 11, 1985
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Jurgen Harting, Andreas Fuchs
  • Hydrocortisone esters, pharmaceutical formulations containing these and processes for their preparation
    Patent number: 4264585
    Abstract: Hydrocortisone esters of the formula ##STR1## wherein R.sup.1 is H, formyl or acetyl and R.sup.2 is H or CH.sub.3 are antiphlogistically active.
    Type: Grant
    Filed: November 8, 1979
    Date of Patent: April 28, 1981
    Assignee: Merck Patent Gesellschaft mit Beschrankter Haftung
    Inventors: Manfred Baumgarth, Dieter Orth, Jurgen Harting
  • Hydrocortisone orthoesters, pharmaceutical formulations thereof and processes for the preparation thereof
    Patent number: 4264584
    Abstract: Hydrocortisone orthoesters of the formula ##STR1## wherein R.sup.1 and R.sup.2 are independently each H or CH.sub.3 and n is 1 or 2 possess antiphlogistic activity.
    Type: Grant
    Filed: November 9, 1979
    Date of Patent: April 28, 1981
    Assignee: Merck Patent Gesellschaft mit Beschrankter
    Inventors: Manfred Baumgarth, Dieter Orth, Jurgen Harting, Hans Schaefer, Achim Zesch
  • 13-Sulfa-prostaglandins
    Patent number: 3932487
    Abstract: Sulfides of the general formula ##SPC1##Wherein R.sub.1 is H or alkyl, R.sub.2 is =O, (H,OH), or (H,lower-acyloxy), R.sub.3 is H, OH or lower-acyloxy, R.sub.4 is alkyl or alkyl substituted by F, OH, lower-acyloxy, phenyl or p-tolyl, and A is alkylene which can be mono- or polysubstituted by F, and the physiologically acceptable salts thereof, possess, in addition to a blood-pressure-lowering activity, prostaglandin-type and antiprostaglandin-type effects.
    Type: Grant
    Filed: November 15, 1973
    Date of Patent: January 13, 1976
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Josef Kramer, Hans Radunz, Dieter Orth, Manfred Baumgarth, Jurgen Harting